Kinfo
Bruker Corporation logo

Bruker Corporation

BRKRNASDAQHealthcare·US · USD
$56.36
+2.95 (+5.52%)
Prices as of August 10, 2026 · market closed

Price

Key statistics

Valuation
Market cap8.13B USD
Enterprise value9.86B USD
Trailing P/E74.88
Forward P/E22.19
PEG ratio-0.92
Price / sales2.33
Price / book3.42
Profitability
Gross margin46.13%
Operating margin9.88%
Profit margin-2.04%
Return on assets3.14%
Return on equity-3.00%
Income (TTM)
Revenue3.50B USD
Gross profit1.70B USD
EBITDA438.00M USD
Net income-106.90M USD
Diluted EPS-$0.70
Rev. growth (YoY)5.20%
Balance sheet
Total cash184.90M USD
Total debt1.86B USD
Debt / equity76.16
Current ratio1.85
Book value / share$15.63
Cash flow (TTM)
Operating cash flow190.40M USD
Levered free cash flow179.94M USD
Shares & price
Shares outstanding152.22M
Float103.70M
Held by institutions92.47%
Beta1.28
50-day MA$58.39
200-day MA$46.21
52-week high$65.30
52-week low$28.53
Dividends
Forward rate
$0.20
Yield
0.37%
Payout ratio
38.46%
Frequency
Quarterly
Recent payments
  • 2026-06-22$0.05
Earnings (EPS)
DateEst.ActualSurprise2026-08-040.380.49+28.95%2026-05-290.740.92+24.32%2026-05-060.230.31+34.78%2026-02-250.160.43+168.75%2026-02-120.650.59−9.23%
About Bruker Corporation

Bruker Corporation is a leading developer and manufacturer of high-performance scientific instruments and analytical solutions that enable molecular and materials research across academic, governmental, and industrial laboratories worldwide. The company designs and distributes nuclear magnetic resonance spectrometers, mass spectrometry platforms, X-ray diffraction instruments, atomic force microscopes, and preclinical imaging systems such as micro-CT and MRI scanners. In addition to hardware, Bruker provides comprehensive software suites, applications support, training services, and long-term maintenance agreements to optimize instrument performance. The company serves diverse customer segments in the pharmaceutical, biotechnology, chemical, semiconductor, energy, and environmental sectors through four primary business segments: Bruker Scientific Instruments BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. With research and development, manufacturing, and service centers located throughout the Americas, Europe, and Asia, Bruker maintains a global infrastructure to support its worldwide customer base. Founded in 1960 and headquartered in Billerica, Massachusetts, the company continues to play a significant role in advancing scientific research and analysis globally.

Sector
Healthcare
Industry
Medical Devices
CEO
Dr. Frank H. Laukien Ph.D.
Employees
11,085
Headquarters
Billerica, MA, United States

Frequently asked questions about Bruker Corporation